Pfizer
Global biopharmaceutical company licensing frontier AI models for drug discovery and co-investing in AI-driven biologics platforms.
- Company type
- Global biopharmaceutical company
- Headquarters
- New York, United States
- Website
- https://www.pfizer.com
- Profile last verified
- 2026-07-29
AI Partnerships & Deployments
- 2026-06-04 — AI drug-discovery license agreement with Chai Discovery (Chai Discovery). Pfizer entered a license agreement to deploy Chai Discovery's AI platform in its drug-discovery engine, gaining early access to the Chai-3 model. Financial terms were not disclosed. Source: Contract Pharma (accessed 2026-07-29)
- 2026-03-23 — Co-investment in Earendil Labs (with Sanofi) (Earendil Labs). Pfizer co-backed AI-driven biologics company Earendil Labs as part of a $787 million financing round alongside Sanofi, supporting Earendil's platform for AI-designed antibodies and biologic therapies. Disclosed: $787M round (co-backed with Sanofi). Source: BioSpace (accessed 2026-07-29)